Muluk S C, Vorp D A, Severyn D A, Gleixner S, Johnson P C, Webster M W
Division of Vascular Surgery, University of Pittsburgh Medical Center, PA, USA.
J Vasc Surg. 1998 Mar;27(3):521-7. doi: 10.1016/s0741-5214(98)70327-1.
Although saphenous vein is the most reliable conduit for arterial interposition procedures in the coronary circulation, graft thrombosis remains a clinical problem. We hypothesized that an important factor in early graft thrombosis is sudden change in the hemodynamic environment of the vein as it is placed in the coronary circulation.
We used an ex vivo perfusion system to study freshly excised segments of human saphenous vein (HSV) and pig internal jugular vein. For coronary graft (CAVG) simulation, sections of HSV were subjected to arterial pulsatile pressure and flow and twisting and stretching to mimic deformations caused by the beating heart. Using functional and immunohistochemical assays, we investigated the effect of these conditions on expression of tissue factor (TF), an important prothrombotic surface molecule.
In each of 11 experiments (6 human, 5 porcine), vein segments from a single donor were subjected to venous conditions (VEN), CAVG perfusion, or no perfusion. Expression of TF was measured as the amount of factor Xa generated per unit area of luminal vein surface. VEN perfusion did not cause a significant change in mean TF expression over nonperfused control values (human: 14.3 +/- 1.5 versus 11.4 +/- 2.3 U/cm2, p = 0.31; pig: 11.6 +/- 1.5 versus 12.5 +/- 1.4 U/cm2, p = 0.70). CAVG perfusion led to significant enhancement of TF expression over VEN perfusion (human: 36.8 +/- 6.2 versus 14.3 +/- 1.5 U/cm2, p < 0.05; pig: 40.0 +/- 9.9 versus 11.6 +/- 1.5 U/cm2, p < 0.05). Immunohistochemical analysis showed positive TF staining on the luminal side of a CAVG-stimulated HSV segment, but not on a VEN-stimulated segment. In four additional studies, HSV segments were subjected to arterial perfusion without twist and stretch to mimic lower extremity arterial interposition grafts. TF expression for lower extremity venous graft perfusion was significantly higher than for VEN perfusion (25.3 +/- 2.5 versus 14.3 +/- 1.5, p < 0.01) but not significantly different from CAVG perfusion.
Our studies in a unique perfusion system suggest that exposure of vein to coronary arterial hemodynamic conditions results in elevated expression of the important prothrombotic molecule TF. This phenomenon may contribute to early graft thrombosis.
尽管大隐静脉是冠状动脉循环中动脉搭桥手术最可靠的血管 conduit,但移植物血栓形成仍然是一个临床问题。我们推测,早期移植物血栓形成的一个重要因素是静脉置于冠状动脉循环时其血液动力学环境的突然变化。
我们使用体外灌注系统研究新鲜切除的人隐静脉(HSV)段和猪颈内静脉。为了模拟冠状动脉移植物(CAVG),HSV段受到动脉搏动压力、血流以及扭曲和拉伸,以模拟由跳动的心脏引起的变形。使用功能和免疫组织化学分析,我们研究了这些条件对组织因子(TF)表达的影响,TF是一种重要的促血栓形成表面分子。
在11项实验(6项人体实验,5项猪实验)中的每一项中,来自单个供体的静脉段分别接受静脉条件(VEN)、CAVG灌注或无灌注。TF的表达以每单位腔静脉表面面积产生的Xa因子量来衡量。VEN灌注与未灌注的对照值相比,平均TF表达没有显著变化(人体:14.3±1.5对11.4±2.3 U/cm2,p = 0.31;猪:11.6±1.5对12.5±1.4 U/cm2,p = 0.70)。CAVG灌注导致TF表达比VEN灌注显著增强(人体:36.8±6.2对14.3±1.5 U/cm2,p < 0.05;猪:40.0±9.9对11.6±1.5 U/cm2,p < 0.05)。免疫组织化学分析显示,CAVG刺激的HSV段腔面有阳性TF染色,而VEN刺激的段没有。在另外四项研究中,HSV段接受无扭曲和拉伸的动脉灌注以模拟下肢动脉搭桥移植物。下肢静脉移植物灌注的TF表达显著高于VEN灌注(25.3±2.5对14.3±1.5,p < 0.01),但与CAVG灌注无显著差异。
我们在独特灌注系统中的研究表明,静脉暴露于冠状动脉血液动力学条件会导致重要的促血栓形成分子TF表达升高。这种现象可能导致早期移植物血栓形成。